Skip to main content

Tadataka Yamada

Tadataka Yamada

1 commentaries

Tadataka Yamada, a venture partner at Frazier Healthcare Partners, was previously Chief Medical and Scientific Officer and a Board Member of Takeda Pharmaceuticals.

Sort by: Show:
  5. op_galbraith7_claffraGetty Images_USdollareconomy
    Subscriber Exclusive

    Dismal Economics

    James K. Galbraith

    Although neoclassical economics relies on assumptions that should have been discarded long ago, it remains the mainstream orthodoxy. Three recent books, and one older one, help to show why its staying power should be regarded as a scandal.

     reviews four books that shed light on the unjustifiable hegemony of the neoclassical school.
    3

Edit Newsletter Preferences

Set up Notification

To receive email updates regarding this {entity_type}, please enter your email below.

If you are not already registered, this will create a PS account for you. You should receive an activation email shortly.